In today’s briefing:
- East Ventures Backs SG Microbiome Firm Bound for Indonesia
East Ventures Backs SG Microbiome Firm Bound for Indonesia
- Amili, a Singapore-based gut microbiome company, has raised an undisclosed sum from East Ventures in a new funding round.
- The fresh funds will be used for its expansion to Indonesia, focusing on addressing gut health issues specific to the local context.
- Amili’s current offerings include gut microbiome sequencing services for healthcare professionals and probiotic formulations tailored to Asian consumers. Microbiome sequencing is a method for studying bacteria to fuel research on disease protection.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
